Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Neuroimage. Clinical|November 30, 2016
Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regionsCourtney A Bishop, Rexford D Newbould, Jean Sz Lee, et al.
Nature Communications|September 3, 2025
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairmentAnnalaura Lerede, Alexandra Moura, Valentina Giunchiglia, et al.
Multiple Sclerosis and Related Disorders|May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapiesAfagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
JAMA Neurology|July 2, 2016
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United KingdomPedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple SclerosisGourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2019
Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosisArman Eshaghi, Rogier A Kievit, Ferran Prados, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridineRichard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Annals of Neurology|December 7, 2023
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple SclerosisSarah Knowles, Rod Middleton, Benjamin Cooze, et al.
BMJ Open|November 26, 2021
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosisRuth Dobson, Matthew Craner, Ed Waddingham, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2024
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in WalesRichard Nicholas, Emma Clare Tallantyre, James Witts, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Neuroimage. Clinical|November 30, 2016
Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regionsCourtney A Bishop, Rexford D Newbould, Jean Sz Lee, et al.
Nature Communications|September 3, 2025
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairmentAnnalaura Lerede, Alexandra Moura, Valentina Giunchiglia, et al.
Multiple Sclerosis and Related Disorders|May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapiesAfagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
JAMA Neurology|July 2, 2016
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United KingdomPedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple SclerosisGourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2019
Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosisArman Eshaghi, Rogier A Kievit, Ferran Prados, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridineRichard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Annals of Neurology|December 7, 2023
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple SclerosisSarah Knowles, Rod Middleton, Benjamin Cooze, et al.
BMJ Open|November 26, 2021
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosisRuth Dobson, Matthew Craner, Ed Waddingham, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2024
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in WalesRichard Nicholas, Emma Clare Tallantyre, James Witts, et al.
Pageof 17